Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 —— 季度财务数据 (NASDAQ:SILO)

Financials

经营活动产生的现金 -917.43 K-1.64 M-1.29 M-955.49 K-780.28 K -4.66 M 投资活动产生的现金 -37.66 K871.38 K388.1 K-95.47 K-519.99 K 644.02 K 融资活动产生的现金 002.09 M634.92 K2.13 M 4.86 M 自由现金流 -917.43 K-1.64 M-1.29 M-955.49 K-780.28 K -4.66 M

新闻

Silo Pharma股价因100万美元股份回购计划而飙升

Silo Pharma stock surges on $1M share buyback program

Silo Pharma授权100万美元股份回购计划

Silo Pharma authorizes $1 million stock buyback program

日本批准Silo Pharma创伤后应激障碍治疗药物专利

Japan grants patent for Silo Pharma’s PTSD treatment

Silo Pharma与Allucent签署意向书，开展SPC-15鼻喷剂临床试验

Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials

Silo Pharma首席执行官Weisblum购入公司价值$735股票

Silo Pharma CEO Weisblum buys $735 in company stock

Silo Pharma selects Allucent to support PTSD treatment IND submission

Silo Pharma selects Alphaledger T12 fund for blockchain asset investments